IDEAYA’s rare cancer drug shows promise as company lays out Phase III plans

IDEAYA’s rare cancer drug shows promise as company lays out Phase III plans

Submitted by admin on September 24, 2024 - 11:54am
Source: 
Clinical Trials Arena
News Tags: 
IDEAYA Biosciences
clinical trials
darovasertib
neoadjuvant uveal melanoma
Headline: 
IDEAYA’s rare cancer drug shows promise as company lays out Phase III plans
snippet: 

IDEAYA Bioscience’s rare cancer drug shows benefit in interim Phase II data, with the company announcing the drugs Phase III trial design.

Do Not Allow Advertisers to Use My Personal information